Close X
Tuesday, November 26, 2024
ADVT 
Health

Scientists create Parkinson's disease in lab

Darpan News Desk IANS, 07 Nov, 2014 11:59 AM
  • Scientists create Parkinson's disease in lab
To unravel what actually goes wrong in people with Parkinson's disease and find out potential new therapy, scientists have successfully created a human stem cell disease model of Parkinson's disease in a dish.
 
The stem cell model allowed scientists to observe key features of the disease in the laboratory, specifically differences in the patients' neurons' ability to produce dopamine, the molecule that is deficient in Parkinson's disease.
 
The researchers studied a pair of identical twins, one affected and one unaffected with Parkinson's disease, another unrelated Parkinson's patient, and four healthy control participants.
 
"The subject of Parkinson's disease discordant twins gave us an incredible opportunity to utilise stem cell models of disease in a dish to unlock some of the biological mechanisms of disease," said Scott Noggle from New York Stem Cell Foundation (NYSCF) Research Institute.
 
Upon analysing the cell models, the scientists found that the dopamine-producing neurons from both twins had reduced GBA enzymatic activity, elevated I-synuclein protein levels, and a reduced capacity to synthesise and release dopamine.
 
In comparison to his unaffected brother, the neurons generated from the affected twin produced less dopamine, had higher levels of an enzyme called monoamine oxidase B (MAO-B), and poor ability to connect with each other.
 
Treating the neurons with molecules that lowered the activity of MAO-B together with overexpressed GBA normalised I -- synuclein and dopamine levels in the cell models.
 
This suggests that a combination therapy for the affected twin may be possible by simultaneously targeting these two enzymes.
 
The findings were published in the journal Cell Reports.

MORE Health ARTICLES

Mild BP control adequate for people above 60

Mild BP control adequate for people above 60
Even a mild dose of drugs used to treat high blood pressure would be adequate for the elderly population who suffer from the condition, a study says....

Mild BP control adequate for people above 60

Research offers hope for patients with cardiovascular disease

Research offers hope for patients with cardiovascular disease
A new research has shown a protein, which controls the growth of new blood vessels, could potentially reduce the effects of cardiovascular disease...

Research offers hope for patients with cardiovascular disease

Premature babies at greater risk of future hip replacements

Premature babies at greater risk of future hip replacements
Low birth weight and premature birth are linked to increased risk of osteoarthritis-related hip replacements in adulthood, says a research....

Premature babies at greater risk of future hip replacements

Nanobodies to help out in boosting immunity

Nanobodies to help out in boosting immunity
Targetting difficult-to-reach areas affected by disease could become a lot easier as researchers have developed a new system to make nanobodies...

Nanobodies to help out in boosting immunity

Cancer cell fingerprints could hasten diagnosis in kids

Cancer cell fingerprints could hasten diagnosis in kids
Cancers in children will be diagnosed faster and more accurately in future as researchers have identified new cancer cell fingerprints in blood....

Cancer cell fingerprints could hasten diagnosis in kids

Dysfunctional protein causes Alzheimer's

Dysfunctional protein causes Alzheimer's
Debunking a prevalent theory of Alzheimer's development, researchers have now found that it is not the amyloid-beta (A-beta) protein fragments but the...

Dysfunctional protein causes Alzheimer's